Cosmetic surgery of the cornea: A new type of surgery

Publication
Article
Ophthalmology Times EuropeOphthalmology Times Europe May 2023
Volume 19
Issue 04

A colourful look at how the keratopigmentation technique offers therapeutic and cosmetic applications.

©Mari Dein / stock.adobe.com
This emerging surgical technique of keratopigmentation has been refined with the modern development of specific surgical instruments. (Image credit ©Mari Dein / stock.adobe.com)

Over the past 10 years, an increasing number of studies have been conducted on the topic of keratopigmentation—that is, the induced cosmetic pigmentation change in the cornea.

Keratopigmentation can be done for therapeutic purposes (eg, for corneal leucomas and blind and disfigured eyes, as well as cases with traumatic aniridia or other problems that affect the eye’s quality of vision).

The topic has been extensively studied and covered in a series of papers that have demonstrated that such techniques are effective, feasible and very useful for patients.1-16

Following this, the purely cosmetic application of this technique has offered the possibility to change the apparent colour of the eye on a voluntary basis. This is purely an aesthetic application that has been obviously disruptive and controversial.

Prof. Jorge L. Alió
Prof. Jorge L. Alió

My colleagues and I first described this technique,7 and it has been practised in Europe by a few surgeons on a continual but selective basis. The biotolerance and local toxicity of the pigments used in keratopigmentation have been the subject of extensive experimental studies.2,6,8 In Figure 1, we display the instruments used in the modern keratopigmentation surgical technique.

Therapeutic keratopigmentation is indeed a new and relevant type of corneal surgery; however, it is still not in general use, essentially because of the insufficient development of pigments specifically for corneal use. Patients with disfigured corneas and blind eyes, and patients who prefer not to go through the trauma associated with evisceration and enucleation and their potential complications, find this new type of surgery to be a very valuable alternative that can successfully restore their appearance in a less invasive manner.1,10

The pigment may be placed inside the corneal stroma when the superficial cornea is transparent (intrastromal keratopigmentation) (Figure 2). With totally opaque corneas, the technique should be performed by applying the pigment on the corneal surface (superficial keratopigmentation)9,11 (Figure 3), either manually or using an automatic device (Figure 4).

In superficial keratopigmentation, the pigment is injected into the superficial corneal stroma up to the level of 140 µm, after denuding the cornel epithelium (Figure 3).

Superficial leucomas are treated with superficial techniques, whereas deep opacities, aniridias and other problems that happen in a patient’s eye are better treated by intralamellar techniques.4,5 Surgical instruments and techniques have also been described in detail in other publications.15 (Figures 1 and 4).

When the superficial corneal stroma is transparent, the intrastromal pigmentation technique can be better used. For this purpose, corneal stromal tunnels are created, assisted by femtosecond laser at the adequate corneal depth,4,5 which also creates a dissection to simulate the pupil at an adequate diameter (Figure 2).

Such corneal tunnels may also be created manually using adequately designed instruments (Figures 1 and 2).

The pigment is matched to the colour of the contralateral normal eye, while the pupil is simulated with black pigment (Figure 5). The main limitation of this technique is the availability of pigments, which are, as of the writing of this article, limited to a few colours and labeled for corneal use with the CE mark. The use of dermatological pigments probably could be acceptable, but the lack of negative effects has not yet been demonstrated on the normal or diseased cornea, as the pigments are made of compounds that are often reactive when in contact with light; thus oxidation may occur. This can lead to a change in the colour over time and might make outcomes of this surgery unpredictable.

Frequently, severely compromised and blind eyes are associated with other disfiguring features such as squint and ptosis, which can also be successfully corrected at the same time as the keratopigmentation procedure is performed. A high level of patient satisfaction has been reported with the use of such combined surgical techniques12 (Figure 6).

Functional disabilities are caused by iris problems such as aniridia, iris atrophy and iris colobomas.3-5 Some of these cases, which either currently have no solution or require extensive and invasive surgeries, may be approached today with intrastromal keratopigmentation. Even intractable diplopias can be solved with keratopigmentation creating a central scotoma by the creation of a simulated pupil of adequate diameter.15,16

Controversial topic

The purely cosmetic use of keratopigmentation is disruptive and controversial because of the voluntary change of colour of the eye that intrinsically has this problem. The procedure is elective, can be performed inadequately and can lead to complications in normal eyes. With respect to this fact, findings from a recent study13 demonstrated that keratopigmentation is, undoubtedly, the best option available for those individuals who wish to change the apparent colour of the eye on a voluntary basis. It demonstrates superior safety to and better outcomes than the alternative approaches using iris colour prosthesis or laser iris depigmentation procedures, which are affected by myriad severe complications that can lead to severe visual loss and even blindness.14 In particular, the use of prosthetic coloured irises should be considered today as a medical malpractice procedure because of the proven severe comorbidities that have been demonstrated to be induced by their implantation in the medium and the long term.

Emerging surgical technique

With this in mind, it should be considered that this emerging surgical technique of keratopigmentation has been refined with the modern development of specific surgical instruments. These include femtosecond lasers and the modern development of pigments. However, the corneal pigments used are considered underdeveloped owing to the main limitation of this technique to be used in general.

Thus, this technique is open to future developments that will be extremely attractive for ophthalmologists, corneal specialists and cosmetic surgeons. It will also be attractive for patients affected by morbidities that affect the cosmetics of their eyes due to disfiguring corneal leucomas. The procedure will also appeal to patients who desire to change their appearance through the colour of their eyes, which should be done for good reason and with appropriate selection by their surgeons.

A new corneal surgical perspective is now available with a good level of published evidence in support. I envision a promising future that will follow this group of new surgical techniques. This topic will probably progress immensely in the coming years along with the increase in clinician experience and the development of more appropriate, specific and diverse corneal pigments.

Jorge L. Alió, MD, PhD, FEBOphth
E: jlalio@vissum.com
Jorge L. Alió, MD, PhD, FEBOphth, is professor and chairman of ophthalmology at Miguel Hernández University, and founder of Vissum Miranza in Alicante, Spain
References
  1. Alio JL, Sirerol B, Walewska-Szafran A, Miranda M. Corneal tattooing (keratopigmentation) with new mineral micronised pigments to restore cosmetic appearance in severely impaired eyes. Br J Ophthalmol. 2010;94(2):245-249. doi:10.1136/bjo.2008.149435
  2. Sirerol B, Walewska-Szafran A, Alio JL, Klonowski P, Rodriguez AE. Tolerance and biocompatibility of micronized black pigment for keratopigmentation simulated pupil reconstruction. Cornea. 2011;30(3):344-350. doi:10.1097/ICO.0b013e3181eae251
  3. Alio JL, Rodriguez AE, Toffaha BT. Keratopigmentation (corneal tattooing) for the management of visual disabilities of the eye related to iris defects. Br J Ophthalmol. 2011;95(10):1397-1401. doi:10.1136/bjophthalmol-2011-300170
  4. Alió JL, Rodriguez AE, Toffaha BT, Piñero DP, Moreno LJ. Femtosecond-assisted keratopigmentation for functional and cosmetic restoration in essential iris atrophy. J Cataract Refract Surg. 2011;37(10):1744-1747. doi:10.1016/j.jcrs.2011.08.003
  5. Alio JL, Rodriguez AE, Toffaha BT, El Aswad A. Femtosecond-assisted keratopigmentation double tunnel technique in the management of a case of Urrets-Zavalia syndrome. Cornea. 2012;31(9):1071-1074. doi:10.1097/ICO.0b013e318243f6b1
  6. Amesty MA, Alio JL, Rodriguez AE. Corneal tolerance to micronised mineral pigments for keratopigmentation. Br J Ophthalmol. 2014;98(12):1756-1760. doi:10.1136/bjophthalmol-2014-305611
  7. Alió JL, Rodriguez AE, El Bahrawy M, Angelov A, Zein G. Keratopigmentation to change the apparent colour of the human eye: a novel indication for corneal tattooing. Cornea. 2016;35(4):431-437. doi:10.1097/ICO.0000000000000745
  8. Amesty MA, Rodriguez AE, Hernández E, De Miguel MP, Alio JL. Tolerance of micronized mineral pigments for intrastromal keratopigmentation: a histopathology and immunopathology experimental study. Cornea. 2016;35(9):1199-1205. doi:10.1097/ICO.0000000000000900
  9. Rodriguez AE, Amesty MA, El Bahrawy M, Rey S, Alio Del Barrio J, Alio JL. Superficial automated keratopigmentation for iris and pupil simulation using micronized mineral pigments and a new puncturing device: experimental study. Cornea. 2017;36(9):1069-1075. doi:10.1097/ICO.0000000000001249
  10. Alio JL, Al-Shymali O, Amesty MA, Rodriguez AE. Keratopigmentation with micronised mineral pigments: complications and outcomes in a series of 234 eyes. Br J Ophthalmol. 2018;102(6):742-747. doi:10.1136/bjophthalmol-2017-310591
  11. Al-Shymali O, Rodriguez AE, Amesty MA, Alio JL. Superficial keratopigmentation: an alternative solution for patients with cosmetically or functionally impaired eyes. Cornea. 2019;38(1):54-61. doi:10.1097/ICO.0000000000001753
  12. Balgos JD, Amesty MA, Rodriguez AE, Al-Shymali O, Abumustafa S, Alio JL. Keratopigmentation combined with strabismus surgery to restore cosmesis in eyes with disabling corneal scarring and squint. Br J Ophthalmol. 2020;104(6):785-789. doi:10.1136/bjophthalmol-2019-314539
  13. D’Oria F, Alio JL, Rodriguez AE, Amesty MA, Abu-Mustafa SK. Cosmetic keratopigmentation in sighted eyes: medium- and long-term clinical evaluation. Cornea. 2021;40(3):327-333. doi:10.1097/ICO.0000000000002417
  14. D’Oria F, Abu-Mustafa SK, Alio JL. Cosmetic change of the apparent colour of the eye: a review on surgical alternatives, outcomes and complications. Ophthalmol Ther. 2022;11(2):465-477. doi:10.1007/s40123-022-00458-2
  15. Alio JL, Amesty MA, Rodriguez A, El Bahrawy M, eds. Text and Atlas on Corneal Pigmentation. 1st ed. Jaypee Brothers Medical Publishers (P) Ltd; 2015.
  16. Laria C, Alió JL, Piñero DN. Intrastromal corneal tattooing as treatment in a case of intractable strabismic diplopia (double binocular vision). Binocul Vis Strabismus Q. 2010;25(4):238-242.
Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Professor Shahina Pardhan, BSC, PhD, MBCO, H DHealth Brad, Director of the Vision and Eye Research Institute, School of Medicine, at Anglia Ruskin University in Cambridge, United Kingdom.
Dr Richard Lindstrom, Chairman of Surface Ophthalmics and founder of Minnesota Eye Consultants, speaks about ASCRS
© 2024 MJH Life Sciences

All rights reserved.